Antineoplastic Agents/Classification Alkylating agents - Action Alter DNA structure by misreading DNA code, initiating breaks in the DNA molecule, cross-linking DNA strands Cell cyle: nonspecific interferes with the replication, transcription and translation of DNA S/S: Bone marrow suppression, N & V, Cystitis, stomatitis, alopecia, gonadal suppression, renal toxicity. Busulfan carboplatin chlorambucil cisplatin- (V) aggressive prehydration 1-2liters of IV fluid is standard therapy before admin. to prevent rental toxicity. (amifostine (Ethyol) – to reduce risk) Renal toxicity cyclophosphamide - cystitis dacarbazine hexamethyl melamine, ifosfamide – Bladder Toxicity - Mesna is admin with to reduce risk melphalan nitrogen mustard - (V) oxaliplatin thiotepa Nitrosureas Action Similar to the alkylating agents; cross the blood –brain barrier. Cell Cycle nonspecific S/S: Delayed and cumulative myelosuppression, especially thrombocytopenia; N & V Carmustine lomustine semustine, streptozocin Mitotic spindle poisons(V) Action Plant alkaloids. Arrest metaphase by inhibiting mitotic tubular formation (spindle); inhibit DNA and prtein synthesis Cell cycle-specific (M phase) Inhibits mitosis by interfering with the mitotic spindle. S/S: bone marrow suppression (mild with VCR), neuropathies (VCR), stomatitis. Bradycardia, hypersensitivity reactions, bone marrow suppression, alopecia, neuropathies vinblastine, VinCRistine – (V) does not have bone marrow suppression but exhibits a dose-limiting neurotxicity. Apply warm/moist compresses for extravasations from vinca alkaloids. (normally cold/moist) Misc: Action Unknown or too complex to categorize Cell cycle - varying S/S:Varies: Anorexia, nausea, vomiting, bone marrow suppression, hepatotoxicity, anaphylaxis, hypotension, altered glucose metabolism Asparaginase Neupogen –stimulates platelet production Epogen - stimulate erythrocyte production Hormonal agents Action Bind to hormone receptor sites that alter cellular growth; block binding of estrogens to receptor sites (anti-estrogens); inhibit RNA synthesis; suppress aromatase of P450 system, which decreases estrogen level. Cell cycle non-specific Used in a number of cancers, but most often used in cancers with receptors for estrogens or adrogens. S/S: Hypercalcemia, jaundice, increased appetite, masculinization, feminization, sodium & fluid retention, N&V, hot flashes, vaginal dryness Androgens and anti-androgens, estrogens and anti-estrogens, progestins and antiprogestins, aromatase inhibitors luteinizing hormone steroids Antimetbolites Action Interfere with the biosynthesis of metabolites or nucleic acids necessary for RNA and DNA synthesis . Cell cyle-specific (S Phase) S/S: N & V , diarrhea, bone marrow suppression, proctitus stomatitis, renal toxicity, hepatotoxicity 5-Azacytadine capecitabine cytararbine edatrexate fludarabine 5-fluorouracil, hydroxyurea, methotrexate, pentostatin Topoisomerase I Inhibitors Action Induces breaks in the DNA strand by binding to enzyme topoisomerase I, preventing cells from dividing . Cell cycle-specific S Phase (McKenry says G2 Phase) S/S: bone marrow suppression, diarrhea, nausea, vomiting hepatotoxicity. Irinotecan, topotecan Antitumor antibiotics (V) Action Interfere with DNA synthesis by binding DNA; prevent RNA synthesis . Cell cycle – nonspecific S/S: bone marrow suppression, N & V, alopecia, anorexia, cardiac toxicity Bleomycin, doxorubicin (V) Cardiac Toxicity Cumulative lifetime dose limit of 550 mg. (Dexrazoxane to help prevent) mitomycin - (V) mitoxantrone Dosage - based on pts total body surface area previous response to chemo or rad therapy function of major organ systems are determined to maximize cell kill while minimizing impact on healthy tissues and subsequent toxicities. Labs: Hematologic, hepatic, renal, cardiovascular, pulmonary systems Dose-limiting effects are adverse effects that prevent a drug from being administered in higher doses tor that indicate caution in continuing to administer the drug at the current dosage. Prednisone does not demonstrate bone marrow suppression or neurtotoixcity. (V) - vesicant if extravasation is suspected, the med admin is stopped immediately and dependent upon drug – an attempt to aspirate any remaining through existing needle. application of heat / cold dependent upon drug. cytoprotectant - amifostine (Ethyol) – scavenger of free radicals that prevents damage to DNA. Protects normal tissue from radiation damage